Skip to main content

Advertisement

Log in

Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico

  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

Cryptococcosis is caused by members of the Cryptococcus neoformans/Cryptococcus gattii species complex. Based on molecular identification, these two species have been further differentiated into molecular types. The aim of this work was to characterize clinical cryptococcal isolates recovered from six hospitals in Northeast Mexico from 1995 to 2011. One hundred and sixty-six isolates, which were characterized by biochemical tests and in vitro susceptibility to amphotericin B, fluconazole, and voriconazole, and M13 PCR fingerprinting, were included in this study. Utilizing phenotypic tests, 153 isolates (92.16 %) were identified as C. neoformans and 13 (7.83 %) as C. gattii. All isolates were susceptible to all antifungals tested. Employing M13 PCR fingerprinting, eight molecular types were detected. VNI was the most common genotype (124 cases; 74.6 %), followed by VNII (15 cases; 9 %), VNIII (8 cases; 4.8 %), VNIV (6 cases; 3.6 %), VGI (6 cases; 3.6 %), VGII (3 cases; 1.8 %), and VGIII and VGIV (2 cases, 1.2 % each). We confirm the presence of C. gattii in clinical isolates in Northeast Mexico, and a high clonal diversity in the studied strains of C. neoformans/C. gattii species complex.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Anandi V, Babu PG, John TJ (1991) Infection due to Cryptococcus neoformans of unusual morphology in a patient with AIDS. Mycoses 34:377–379

    Article  PubMed  CAS  Google Scholar 

  • Arguero Licea B, Cervantes Olivares A (1999) Isolation and characterization of C. neoformans var. gattii from samples of Eucalyptus canaldulensis in Mexico City. Rev Iberoam Micol 16:40–42

    PubMed  CAS  Google Scholar 

  • Bennett JE, Kwon-Chung KJ, Howard DH (1977) Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 105:582–586

    PubMed  CAS  Google Scholar 

  • Bertout S, Renaud F, Swinne D, Mallie M, Bastide JM (1999) Genetic multilocus studies of different strains of Cryptococcus neoformans: taxonomy and genetic structure. J Clin Microbiol 37:715–720

    PubMed  PubMed Central  CAS  Google Scholar 

  • Bertout S, Drakulovski P, Kouanfack C, Krasteva D, Ngouana T, Dunyach-Rémy C, Dongtsa J, Aghokeng A, Delaporte E, Koulla-Shiro S, Reynes J, Mallié M (2013) Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients. Clin Microbiol Infect 19:763–769

    Article  PubMed  CAS  Google Scholar 

  • Bicanic T, Wood R, Bekker LG, Darder M, Meintjes G, Harrison TS (2005) Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis. Lancet Infect Dis 5:530–531

    Article  PubMed  Google Scholar 

  • Boekhout T, van Belkum A (1997) Variability of karyotypes and RAPD types in genetically related strains of Cryptococcus neoformans. Curr Genet 32:203–208

    Article  PubMed  CAS  Google Scholar 

  • Bovers M, Hagen F, Boekhout T (2008) Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol 25:S4–S12

    Article  PubMed  Google Scholar 

  • Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL, Rimland D, Warnock DW (2001) Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother 45:3065–3069

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Canónico-González Y, Adame-Rodríguez JM, Mercado-Hernández R, Aréchiga-Carvajal ET (2013) Cryptococcus spp. isolation from excreta of pigeons (Columba livia) in and around Monterrey, Mexico. Springerplus 23:632

  • Chandenier J, Adou-Bryn KD, Douchet C, Sar B, Kombila M, Swinne D, Thérizol-Ferly M, Buisson Y, Richard-Lenoble D (2004) In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia. Eur J Clin Microbiol Infect Dis 23:506–508

    Article  PubMed  CAS  Google Scholar 

  • Chayakulkeeree M, Perfect JR (2006) Cryptococcosis. Infect Dis Clin N Am 20:507–544

    Article  Google Scholar 

  • Chong HS, Dagg R, Malik R, Chen S, Carter D (2010) In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol 48:4115–4120

    Article  PubMed  PubMed Central  Google Scholar 

  • CLSI (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standards, 3er ed. M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA

  • Cogliati M (2013) Global molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii: an atlas of the molecular types. Scientifica 2013:675213

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Currie BP, Freundlich LF, Casadevall A (1994) Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol 32:1188–1192

    PubMed  PubMed Central  CAS  Google Scholar 

  • Datta K, Jain N, Sethi S, Rattan A, Casadevall A, Banerjee U (2003) Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care center in India: a need for care. J Antimicrob Chemother 52:683–686

    Article  PubMed  CAS  Google Scholar 

  • Franzot SP, Hamdan JS, Currie BP, Casadevall A (1997) Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J Clin Microbiol 35:2243–2251

    PubMed  PubMed Central  CAS  Google Scholar 

  • Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, Diezmann S, Allen A, Stajich JE, Dietrich FS, Perfect JR, Heitman J (2005) Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437:1360–1364

    Article  PubMed  CAS  Google Scholar 

  • Freire AK, dos Santos Bentes A, de Lima Sampaio I, Matsuura AB, Ogusku MM, Salem JI, Wanke B, de Souza JV (2012) Molecular characterization of the causative agents of Cryptococcosis in patients of a tertiary healthcare facility in the state of Amazonas-Brazil. Mycoses 55:e145–e150

    Article  PubMed  Google Scholar 

  • Gomez-Lopez A, Zaragoza O, Dos Anjos Martins M, Melhem MC, Rodriguez-Tudela JL, Cuenca-Estrella M (2008) In vitro susceptibility of Cryptococcus gattii clinical isolates. Clin Microbiol Infect 14:727–730

    Article  PubMed  CAS  Google Scholar 

  • Hagen F, Illnait-Zaragozi MT, Bartlett KH, Swinne D, Geertsen E, Klaassen CH, Boekhout T, Meis JF (2010) In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 54:5139–5145

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hagen F, Illnait-Zaragozí MT, Meis JF, Chew WH, Curfs-Breuker I, Mouton JW, Hoepelman AI, Spanjaard L, Verweij PE, Kampinga GA, Kuijper EJ, Boekhout T, Klaassen CH (2012) Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population. J Clin Microbiol 50:1918–1926

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hagen F, Ceresini PC, Polacheck I, Ma H, van Nieuwerburgh F, Gabaldón T, Kagan S, Pursall ER, Hoogveld HL, van Iersel LJ, Klau GW, Kelk SM, Stougie L, Bartlett KH, Voelz K, Pryszcz LP, Castañeda E, Lazera M, Meyer W, Deforce D, Meis JF, May RC, Klaassen CH, Boekhout T (2013) Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS ONE 8:e71148

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hanafy A, Kaocharoen S, Jover-Botella A, Katsu M, Iida S, Kogure T, Gonoi T, Mikami Y, Meyer W (2008) Multilocus microsatellite typing for Cryptococcus neoformans var. grubii. Med Mycol 46:685–696

    Article  PubMed  CAS  Google Scholar 

  • Igreja RP, Lazéra Mdos S, Wanke B, Galhardo MC, Kidd SE, Meyer W (2004) Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Med Mycol 42:229–238

    Article  PubMed  CAS  Google Scholar 

  • Illnait-Zaragozí MT, Martínez-Machín GF, Fernández-Andreu CM, Hagen F, Boekhout T, Klaassen CH, Meis JF (2010) Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitis. BMC Infect Dis 4:289

    Article  CAS  Google Scholar 

  • Iqbal N, DeBess EE, Wohrle R, Sun B, Nett RJ, Ahlquist AM, Chiller T, Lockhart SR, Crytococcus gattii Public Health Working Group (2010) Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol 48:539–544

  • Kidd SE, Bach PJ, Hingston AO, Mak S, Chow Y, MacDougall L, Kronstad JW, Bartlett KH (2007) Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerg Infect Dis 13:51–57

    Article  PubMed  PubMed Central  Google Scholar 

  • Loperena-Alvarez Y, Ren P, Li X, Schoonmaker-Bopp DJ, Ruiz A, Chaturvedi V, Rios-Velazquez C (2010) Genotypic characterization of environmental isolates of Cryptococcus gattii from Puerto Rico. Mycopathologia 170:279–285

    Article  PubMed  Google Scholar 

  • Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E, IberoAmerican Cryptococcal Study Group (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9:189–195

    Article  PubMed  PubMed Central  Google Scholar 

  • Mitchell TG, Perfect JR (1995) Cryptococcosis in the era of AIDS—100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8:515–548

    PubMed  PubMed Central  CAS  Google Scholar 

  • Nussbaum JC, Jackson A, Namarika D, Phulusa J, Kenala J, Kanyemba C, Jarvis JN, Jaffar S, Hosseinipour MC, Kamwendo D, van der Horst CM, Harrison TS (2010) Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Clin Infect Dis 50:338–344

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Olivares LR, Martinez KM, Cruz RM, Rivera MA, Meyer W, Espinosa RA, Martinez RL, Santos GM (2009) Genotyping of Mexican Cryptococcus neoformans and C. gattii isolates by PCR-fingerprinting. Med Mycol 47:713–721

    Article  PubMed  CAS  Google Scholar 

  • Perfect JR, Magee BB, Magee PT (1989) Separation of chromosomes of Cryptococcus neoformans by pulsed field gel electrophoresis. Infect Immun 57:2624–2627

    PubMed  PubMed Central  CAS  Google Scholar 

  • Perkins A, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M (2005) Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrob Chemother 56:1144–1447

    Article  PubMed  CAS  Google Scholar 

  • Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Doern GV, Diekema DJ (2005) Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 43:2163–2167

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Stephen C, Lester S, Black W, Fyfe M, Ravenrtry S (2002) Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J 43:792–794

    PubMed  PubMed Central  Google Scholar 

  • Trilles L, Meyer W, Wanke B, Guarro J, Lazéra M (2012) Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol 50:328–332

    Article  PubMed  Google Scholar 

  • Tseng HK, Liu CP, Ho MW, Lu PL, Lo HJ, Lin YH, Cho WL, Chen YC, Taiwan Infectious Diseases Study Network for Cryptococcosis (2013) Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997–2010. PLoS ONE 8:e61921

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tsujisaki RA, Paniago AM, Lima Júnior MS, Alencar Dde S, Spositto FL, Nunes Mde O, Trilles L, Chang MR (2013) First molecular typing of cryptococcemia-causing Cryptococcus in central-west Brazil. Mycopathologia 176:267–272

    Article  PubMed  CAS  Google Scholar 

  • Yildiran ST, Fothergill AW, Sutton DA, Rinaldi MG (2002) In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole. Mycoses 45:378–383

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Virgilio Bocanegra-Garcia.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

González, G.M., Casillas-Vega, N., Garza-González, E. et al. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico. Folia Microbiol 61, 51–56 (2016). https://doi.org/10.1007/s12223-015-0409-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12223-015-0409-8

Keywords

Navigation